ULT Ultrasis

TIDMULT

Ultrasis PLC

04 February 2014

Ultrasis plc

("Ultrasis" or "the Company)

Screenetics chosen by Xexec as part of major public sector contract

Ultrasis the provider of healthcare and wellness services is pleased to provide further details that its Health screening and wellbeing company, Screenetics, has been chosen as the exclusive provider of a range of health screening options as part of a large public sector salary sacrifice scheme which was recently awarded to Xexec.

The Mayor's Office for Policing and Crime (MOPAC) selected Xexec as its provider of choice to deliver a combined employee benefits programme to the Metropolitan Police Service's (MPS) 45,000 staff following a rigorous tender process. The Framework Agreement will also be open to elected local policing bodies and other police authorities, for UK police forces, the Greater London Authority (GLA) and UK Fire & Rescue Services, with a total head count of 335,094.

The service, incorporating Xexec's lifestyle discounts product, will be delivered under the banner 'Met Offers'. In addition to the Screentics health screening product, Xexec will offer childcare vouchers via Computershare Voucher Services and cycle-to-work through the choice of either Evans Cycles or Halfords.

Saul Meyer, Xexec CEO, says: "We're delighted to be working with the Metropolitan Police Service on this ambitious programme. Our experience with the Department for Work and Pensions, the Ministry of Justice, the Foreign and Commonwealth Office, HMRC, the Department for Education, and other public sector clients has helped position Xexec as a credible and reliable provider of combined benefits and recognition programmes and we hope to create an exciting and engaging benefits package for all MPS staff". He added: "We look forward to working closely with Screenetics as our provider for the screening elements of this program and to implementing the bespoke solution Screenetics have created for this contract with Xexec."

"We are naturally delighted to be working with Xexec and the other providers to deliver this unique contract to the Metropolitan Police Services and the wider public sector organisations who can use this framework agreement. We expect to see significant interest from the employees and their families and believe that the Screenetics team will offer considerable benefit to their health and wellbeing. " says Ultrasis chief Executive John Smith.

"Salary sacrifice schemes are tax efficient ways for employees to benefit from a regular annual health check. Just like you MOT your car it's about giving your body an MOT to ensure that everything is in tip top condition." said Kevin Hollick, Managing Director at Screenetics. He added "Our experience of providing services to similar salary sacrifice schemes indicates a typical take up of around 3-5% of the workforce but we hope that with targeted marketing and the high level of health awareness amongst the employees this will be exceeded and lead to significant income to the company over the next 3 years."

Ends

Media enquiries:

For all enquiries relating to Ultrasis please contact

 
Ultrasis plc                 Tel: +44 (0) 20 7535 2050 
John Smith, Chief Executive 
 
finnCap Limited              Tel: +44 (0) 20 7220 0500 
Geoff Nash/Simon Hicks 
 
JBP Public Relations         Tel: +44 (0) 11 7907 3400 
Chris Lawrance 
 

Notes to Editors

Ultrasis is a healthcare company with core expertise in health, psychology, software development and programme management. We deliver a range of healthcare products to the consumer, the NHS, the corporate sector and other healthcare providers in the UK and Internationally. Ultrasis was the first company to offer computerised products based on Cognitive Behavioural Therapy (CBT) and interactive multimedia, and is still the world leader in this field.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRALLFELFFISIIS

Ultrasis (LSE:ULT)
Historical Stock Chart
From Jan 2025 to Feb 2025

Ultrasis (LSE:ULT)
Historical Stock Chart
From Feb 2024 to Feb 2025